Clinical Trial

Effectiveness of Posluma PET Scan for Post-Treatment Monitoring of Prostate Cancer

Name: Effectiveness of Posluma PET Scan for Post-Treatment Monitoring of Prostate Cancer — clinical trial record (NCT07733908)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

To determine the effectiveness of Posluma PET Scan for monitoring prostate cancer patients after targeted treatment, including how accurately it can detect any remaining or returning cancer after about 12 months post-treatment.

Trial Details

NCT Number	NCT07733908
Lead Sponsor	Aditya Bagrodia Collaborators: Blue Earth Diagnostics
Conditions	Prostate Cancer
Enrollment	22 participants
Start Date	2026-08
Primary Completion	2030-07 (estimated)
Study Completion	2030-07 (estimated)
Updated on ClinicalTrials.gov	2026-08-14